Zhao Zhonghai, Lv Bin, Zhang Li, Zhao Nana, Lv Yan
Department of Thoracic Surgery, Yidu Central Hospital of Weifang, Qingzhou, Shandong 262500, P.R. China.
Department of Thoracic Surgery, Anqiu People's Hospital, Anqiu, Shandong 262100, P.R. China.
Mol Med Rep. 2017 Aug;16(2):2281-2289. doi: 10.3892/mmr.2017.6841. Epub 2017 Jun 22.
MicroRNAs (miRNAs) are a group of non-protein‑coding, short single-stranded RNAs, which are considered as promising molecular markers and therapeutic targets in several cancers. The present study explored the expression patterns and functional roles of miR‑202 in non‑small cell lung cancer (NSCLC). The expression levels of miR‑202 were determined in NSCLC tissues and cell lines using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The functional impact of miR‑202 overexpression on NSCLC cell viability, migration and invasion were evaluated using Cell Counting Kit‑8 reagent and Transwell migration and invasion assays, respectively. The molecular mechanism underlying the tumor suppressive roles of miR‑202 on NSCLC was examined using bioinformatics analysis, luciferase reporter assay, RT‑qPCR and western blot analysis. In addition, signal transducer and activator of transcription (STAT) 3 was overexpressed to investigate the impact on miR‑202‑mediated tumor suppression in NSCLC. The results indicated that miR‑202 was downregulated in NSCLC tissues and cell lines, and was associated with tumor node metastasis stage and lymph node metastasis. Exogenous miR‑202 expression reduced NSCLC cell viability, migration and invasion. Furthermore, STAT3 was identified as a direct target gene of miR‑202 in NSCLC. STAT3 overexpression improved miR‑202‑impaired cell viability, migration and invasion. In conclusion, the present study revealed novel anticancer effects induced by miR‑202 upregulation in NSCLC, and indicated that STAT3 may be a molecular target of miR‑202.
微小RNA(miRNA)是一组非蛋白质编码的短单链RNA,被认为是多种癌症中有前景的分子标志物和治疗靶点。本研究探讨了miR-202在非小细胞肺癌(NSCLC)中的表达模式和功能作用。采用逆转录定量聚合酶链反应(RT-qPCR)检测NSCLC组织和细胞系中miR-202的表达水平。分别使用细胞计数试剂盒-8试剂以及Transwell迁移和侵袭试验评估miR-202过表达对NSCLC细胞活力、迁移和侵袭的功能影响。采用生物信息学分析、荧光素酶报告基因检测、RT-qPCR和蛋白质印迹分析,研究miR-202对NSCLC的肿瘤抑制作用的分子机制。此外,过表达信号转导子和转录激活子(STAT)3,以研究其对NSCLC中miR-202介导的肿瘤抑制的影响。结果表明,miR-202在NSCLC组织和细胞系中表达下调,且与肿瘤结节转移分期和淋巴结转移相关。外源性miR-202表达降低了NSCLC细胞的活力、迁移和侵袭能力。此外,STAT3被确定为NSCLC中miR-202的直接靶基因。STAT3过表达改善了miR-202受损的细胞活力、迁移和侵袭能力。总之,本研究揭示了miR-202上调在NSCLC中诱导的新型抗癌作用,并表明STAT3可能是miR-202的分子靶点。